ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
62,772.89
-0.19%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vaccinex Inc (VCNX)

  7. Vaccinex Inc (VCNX) Noticias

VCNX Vaccinex Inc

6.05
-0.13 (-2.10%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Vaccinex Inc VCNX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.13 -2.10% 6.05 16:16:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.01 6.01 6.59 6.05 6.18
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/4/202407:30GLOBEVaccinex Reports 2023 Financial Results and Provides..
27/3/202407:30GLOBEVaccinex, Inc. Announces $1.5 Million Registered Direct..
04/3/202415:19EDGAR2Form 8-K - Current report
21/2/202409:10EDGAR2Form 8-K - Current report
21/2/202407:00GLOBEVaccinex Announces Multiple New Agreements for Access to..
15/2/202407:06EDGAR2Form 8-K - Current report
15/2/202407:00GLOBEVaccinex, Inc. Announces Reverse Stock Split
13/2/202415:30EDGAR2Form 8-K - Current report
13/2/202415:15EDGAR2Form SC 13D/A - General statement of acquisition of..
12/2/202415:22EDGAR2Form SC 13D/A - General statement of acquisition of..
09/2/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/2/202407:20EDGAR2Form 8-K/A - Current report: [Amend]
07/2/202414:43EDGAR2Form 8-K - Current report
07/2/202407:00GLOBEVaccinex Announces Pricing of $3.7 Million PIPE Financing
21/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
19/1/202415:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/1/202416:16EDGAR2Form S-3 - Registration statement under Securities Act of..
08/1/202415:16EDGAR2Form DEF 14A - Other definitive proxy statements
28/12/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202315:15EDGAR2Form PRE 14A - Other preliminary proxy statements
12/12/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202307:00GLOBENasdaq Grants Vaccinex Extension Until March 4, 2024 to..
13/11/202307:00GLOBEVaccinex Reports Third Quarter 2023 Financial Results and..
13/11/202306:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202308:00GLOBEVaccinex Reports Clinical Benefit in Interim Analyses from..
26/10/202308:30EDGAR2Form 8-K - Current report
26/10/202308:30GLOBEVaccinex Reports Positive Effect of Pepinemab Treatment on..
25/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202315:15EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202315:54EDGAR2Form 8-K - Current report
12/10/202315:30EDGAR2Form SC 13D/A - General statement of acquisition of..
05/10/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202308:20EDGAR2Form 8-K - Current report
02/10/202308:16EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
28/9/202319:41EDGAR2Form S-1MEF - Registration adding securities to prior Form..
27/9/202307:00EDGAR2Form 8-K - Current report
26/9/202315:15EDGAR2Form SC 13D/A - General statement of acquisition of..
26/9/202307:06EDGAR2Form 8-K - Current report
26/9/202307:01EDGAR2Form S-1/A - General form for registration of securities..
25/9/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202315:37EDGAR2Form 8-K - Current report
22/9/202315:21EDGAR2Form 8-K - Current report
14/9/202316:26EDGAR2Form S-1 - General form for registration of securities under..
13/9/202305:46EDGAR2Form 8-K - Current report
22/8/202315:31EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
VCNX
Vaccinex
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados